Search Within

Eric J Sherman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (15)
  3. Guidelines (1)
Groups
  1. Department of Medicine (38)
  2. GSK Faculty (38)
  3. Head and Neck Service (38)
  4. Human Oncology and Pathogenesis Program (38)
  5. Solid Tumor Oncology Division (38)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (36)

More Groups

People
  1. James Fagin (35)
  2. Ronald Ghossein (21)
  3. Alan Ho (20)
  4. Robert Tuttle (19)
  5. David Pfister (15)
  6. Mona Sabra (11)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (9)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Thyroid (5)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Annals of Oncology (2)
  5. Cancer (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (5)
  3. Mary Ann Liebert, Inc (5)
  4. Wiley Blackwell (4)
  5. Elsevier Inc. (3)
  6. Nature Publishing Group (3)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion
    Journal Article

    Dogan, S.; Wang, L.; Ptashkin, R. N.; Dawson, R. R.; Shah, J. P.; Sherman, E. J.; Tuttle, R. M.; Fagin, J. A.; Klimstra, D. S.; Katabi, N.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer
    Journal Article

    Romesser, P. B.; Sherman, E. J.; Shaha, A. R.; Lian, M.; Wong, R. J.; Sabra, M.; Rao, S. S.; Fagin, J. A.; Tuttle, R. M.; Lee, N. Y.
    Journal of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Lipson, B. L.; Kurz, S.; Fagin, J. A.; Pfister, D. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF mutant thyroid carcinomas
    Meeting Abstract

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas
    Journal Article

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus/sorafenib in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Korte, S. H.; Smith-Marrone, S.; Xiao, H.; Ghossein, R. A.; Fagin, J. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib
    Meeting Abstract

    Ho, A. L.; Leboeuf, R.; Grewal, R. K.; Sherman, E. J.; Deandreis, D.; Pentlow, K. S.; Tuttle, R. M.; Fury, M. G.; Ricarte-Filho, J. C. M.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save